When a privately held startup hits $1 billion in value, it magically transforms from an ugly mare into a beautiful unicorn (or so the legend goes). In the 3D printing space, there are three such creatures and we’ll be profiling each one, beginning with the oldest: Formlabs.
The Boston-based company was born out of MIT Media Lab, where its co-founders, Maxim Lobovsky, Natan Linder and David Cranor met as students learning about the newly hyped technology of 3D printing. The trio went on to establish Formlabs in September 2011 with the Form 1.
What made the Form 1 so remarkable was that it was the first desktop SLA 3D printer, bringing quality associated with much more expensive systems to under $5,000 (the original base package was just $2299 for early birds). And it did so via Kickstarter, raising nearly $3 million and becoming one of the most successful crowdfunding campaigns for 3D printing.
The firm continued to sell and develop, which is a lot more than can be said for some other crowdfunded companies (looking at you, Pirate3D). This resulted in the release of the Form 1+, Form 2, Form 3 and Form 3L, all representing improvements in the hardware architecture and/or size of the printer. Most recently, the company added the Form 3B, dedicated to biocompatible materials, including resins for 3D printing surgical guides.
With the Form 3 and 3L (released in 2019), Formlabs introduced “low force stereolithography (LFS),” a re-engineering of its previous SLA process, wherein the forces of suction of the part on the optical window were too strong for certain geometries and materials. In LFS, a redesigned optics system made up of lenses, mirrors and a galvanometer directs a laser beam directly perpendicular to the build plane, resulting in the ability to print in finer details and lighter support structures. The optical window, and indeed the frame holding it, flex which reduces the forces acting on the part.
But Formlabs didn’t limit itself to just SLA or even LFS. In 2017, the firm confirmed it was working on the Fuse 1, one of a very low number of desktop SLS 3D printers. By this point, it was more clear than ever that Formlabs wasn’t just a startup, but was evolving into something more… majestic? Well, at least something much more significant because it was no longer just selling printers on Kickstarter, but had established a global presence mainly selling direct but also an extensive reseller and distribution network.
That isn’t to say that it didn’t face its share of obstacles. Along the way, in 2012, it was sued by the original inventor of SLA, 3D Systems, for patent infringement before the two reached a licensing settlement netting the larger of the two companies 8% of every sale. Formlabs was sued once again in 2016 by DLP inventor EnvisionTEC. The startup had officially made the big leagues.
In fact, the company is so substantial at this point that it’s not just being sued by the big dogs, but it’s becoming a big dog itself. Formlabs announced its first acquisition, that of Spectra Group Photopolymers, who has supplied its parent company with resins since the Form 1 days. With the purchase, Formlabs will be investing over $1 million into renovating Spectra’s facilities to become an FDA registered, ISO Class 8 certified cleanroom in an ISO 13485 certified facility for dental and medical materials development.
After early seed funding from investors that included Eric Schmidt’s Innovation Endeavors, the startup concluded Series A Funding of $19 million in 2013. Series A led to Series B ($35 million in 2016), which led to Series C ($30 million in 2018). With a $15 million infusion (also in 2018), Formlabs added former GE CEO Jeff Immelt to its board of directors. At this point, the startup was valued at over $1 billion, officially transforming Formlabs from a beast of burden into a mythical unicorn.
Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.
You May Also Like
3D Scanning & 3D Printing Used in Digital Workflow to Design & Build Custom Neck Orthosis
Custom orthotics made through conventional manufacturing methods require casting, sculpting, molding, and fitting to be completed before they’re ready for the patient to wear. It can take up to six...
Cell Culture Bioreactor for Tissue Engineering
Researchers from the US and Portugal are refining tissue engineering applications further, releasing the findings of their study in the recently published ‘A Multimodal Stimulation Cell Culture Bioreactor for Tissue...
3D Printed Guide and Titanium Implant Help Surgeons Reconstruct Patient’s Pelvic Bone
Cancer patients with pelvic sarcomas need a large bone transplantation and implant fixation after resection of the bone defect, but complex implant systems often fall apart in many patients shortly...
3D Printing: Successful Scaffolds in Bone Regeneration
In ‘Comprehensive Review on Full Bone Regeneration through 3D Printing Approaches,’ the authors review new developments and solutions in tissue engineering for the formation of cells, as well as proposing...
View our broad assortment of in house and third party products.